ArticlePloS one2023

Significant expansion of the donor pool achieved by utilizing islets of variable quality in the production of allogeneic "Neo-Islets", 3-D organoids of Mesenchymal Stromal and islet cells, a novel immune-isolating biotherapy for Type I Diabetes.

Anna M Gooch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.